Alexander Zukiwski Net Worth

Alexander Zukiwski biography

Dr. Alexander A. Zukiwski is Chief Medical Officer of the Company. Dr. Zukiwski joined the Company in April of 2017 as Chief Medical Officer. Prior to joining the Company, Dr. Zukiwski was Chief Executive Officer and Chief Medical Officer of Arno Therapeutics and has been a Director of Arno Therapeutics since 2014. At Arno, his responsibilities included leading the clinical development and regulatory affairs teams to support the company’s pipeline. Prior to Arno in 2007, Dr. Zukiwski served as Chief Medical Officer and Executive Vice President of Clinical Research at MedImmune. Prior to MedImmune, Dr. Zukiwski held several roles of increasing responsibility at Johnson & Johnson’s (J&J) medical affairs and clinical development functions at Johnson & Johnson Pharmaceutical Research & Development LLC (J&JPRD); Centocor R&D and Ortho Biotech. Before joining J&J, he served in clinical oncology positions at pharmaceutical companies such as Hoffmann-LaRoche, Glaxo Wellcome and Rhone- Poulenc Rorer. Dr. Zukiwski has more than 21 years of experience in global drug development and supported the clinical evaluation and registration of many successful oncology therapeutic agents, including Taxotere®, Xeloda®, Procrit®/Eprex®, Velcade®, Yondelis®, and Doxil®. He previously served as a Member of Medical Advisory Board at Gem Pharmaceuticals, LLC and served as a Director of Ambit Biosciences Corporation. Dr. Zukiwski holds a bachelor’s degree in pharmacy from the University of Alberta and a Doctor of Medicine degree from the University of Calgary. He conducted his post-graduate training at St. Thomas Hospital Medical Center in Akron, Ohio and the University of Texas MD Anderson Cancer Center.

What is the salary of Alexander Zukiwski?

As the Chief Medical Officer of CASI Pharmaceuticals Inc, the total compensation of Alexander Zukiwski at CASI Pharmaceuticals Inc is $961,350. There are 1 executives at CASI Pharmaceuticals Inc getting paid more, with Wei-Wu He having the highest compensation of $9,269,690.

How old is Alexander Zukiwski?

Alexander Zukiwski is 62, he's been the Chief Medical Officer of CASI Pharmaceuticals Inc since 2017. There are 3 older and 6 younger executives at CASI Pharmaceuticals Inc. The oldest executive at CASI Pharmaceuticals Inc is Rajesh Shrotriya, 76, who is the Independent Director.

What's Alexander Zukiwski's mailing address?

Alexander's mailing address filed with the SEC is CASI PHARMACEUTICALS, INC., 9620 MEDICAL CENTER DRIVE, SUITE 300, ROCKVILLE, MD, 20850.

Insiders trading at CASI Pharmaceuticals Inc

Over the last 12 years, insiders at CASI Pharmaceuticals Inc have traded over $0 worth of CASI Pharmaceuticals Inc stock and bought 30,834,178 units worth $51,898,666 . The most active insiders traders include Wei Wu He, Rajesh C Md Shrotriya e Pharmaceuticals Inc Spectru.... On average, CASI Pharmaceuticals Inc executives and independent directors trade stock every 91 days with the average trade being worth of $6,141,555. The most recent stock trade was executed by James Huang on 6 September 2022, trading 55,573 units of CASI stock currently worth $229,516.

What does CASI Pharmaceuticals Inc do?

CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. The Company intends to execute its plan to become a leader by launching medicines in the Greater China market leveraging the Company’s China-based regulatory and commercial competencies and its global drug development expertise. The Company’s operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals (China) Co., Ltd. (“CASI China”), which is located in Beijing, China. The Company has built a commercial team of over 70 hematology and oncology sales and marketing specialists based in China.

CASI Pharmaceuticals Inc executives and stock owners

CASI Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Wei-Wu He,
  Executive Chairman of the Board, Chief Executive Officer
• Alexander Zukiwski,
  Chief Medical Officer
• Wei Zhang,
  President, President of CASI China, Interim Principal Financial Officer
• Dr. Wei-Wu He Ph.D.,
  Chairman & CEO
• Dr. Wei Zhang Ph.D.,
  Pres & Principal Financial Officer
• Dr. Alexander A. Zukiwski M.D.,
  Exec. VP & Chief Medical Officer
• James Huang,
  Independent Director
• Y. Alexander Wu,
  Independent Director
• Franklin Salisbury,
  Independent Director
• Quan Zhou,
  Independent Director
• Rajesh Shrotriya,
  Independent Director
• Amanda Cui,
  VP & Global Controller
• Dr. James E. Goldschmidt Ph.D.,
  Chief Bus. Devel. Officer
• Sara B. Capitelli CPA,
  VP of Fin.
• Byte Ltdsnow Moon Ltdtianji...,
  
• Ken Ren,
  CEO and Director
• Pharmaceuticals Inc Spectru...,
  
• Alex Wu,
  Director
• Tak W. Mak,
  Director
• China Growth Fund Iii L.P.I...,
  
• Strategy Holding Ltd Wealth,
  10% owner
• Sara B Capitelli,
  VP, Finance & PAO
• George Chi,
  Chief Financial Officer
• Cynthia W. Hu,
  See Remarks
• Byte Ltdsnow Moon Ltdtianji...,
  
• Ken Keyong Ren,
  Chief Executive Officer
• Larry Zhang,
  President
• Weihao Xu,
  Chief Financial Officer